Related Experiment Video
Updated: Apr 14, 2026

Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
Published on: February 7, 2020
Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences
Jun-Qin Wang1, Rui-Rui Qi1, Wei Zhou1
1Department of Nautical Injury Prevention, Faculty of Navy Medicine, Second Military Medical University, Shanghai, China.
Objective:
To identify differentially expressed genes associated with motion sickness (MS) susceptibility in the rat caudal vestibular nucleus.
Methods:
We identified MS susceptible (MSS) and insusceptible (inMSS) rats by quantifying rotation-induced MS symptoms: defecation and spontaneous locomotion activity. Microarray analysis was used to screen differentially expressed genes in the caudal vestibular nucleus (CVN) after rotation. Plasma stress hormones were identified by radioimmunoassay. Candidate genes were selected by bioinformatics analysis and the microarray results were verified by real-time quantitative-PCR (RT-qPCR) methods. By using Elvax implantation, receptor antagonists or recombinant adenovirus targeting the candidate genes were applied to the CVN to evaluate their contribution to MS susceptibility variability. Validity of gene expression manipulation was verified by RT-qPCR and western blot analysis.
Results:
A total of 304 transcripts were differentially expressed in the MSS group compared with the inMSS group. RT-qPCR analysis verified the expression pattern of candidate genes, including nicotinic cholinergic receptor (nAchR) α3 subunit, 5-hydroxytryptamine receptor 4 (5-HT4R), tachykinin neurokinin-1 (NK1R), γ-aminobutyric acid A receptor (GABAAR) α6 subunit, olfactory receptor 81 (Olr81) and homology 2 domain-containing transforming protein 1 (Shc1). In MSS animals, the nAchR antagonist mecamylamine significantly alleviated rotation-induced MS symptoms and the plasma β-endorphin response. The NK1R antagonist CP99994 and Olr81 knock-down were effective for the defecation response, while the 5-HT4R antagonist RS39604 and Shc1 over-expression showed no therapeutic effect. In inMSS animals, rotation-induced changes in spontaneous locomotion activity and the plasma β-endorphin level occurred in the presence of the GABAAR antagonist gabazine.
Conclusion:
Our findings suggested that the variability of the CVN gene expression profile after motion stimulation might be a putative molecular basis for individual differences in MS susceptibility and provide information for the development of new therapeutic strategies for MSS individuals.
Insights
Motion sickness susceptibility in rats is linked to gene expression changes in the caudal vestibular nucleus. Targeting specific receptors like nicotinic cholinergic receptor alpha3 subunit and tachykinin neurokinin-1 receptor may offer therapeutic strategies.
Area of Science:
- Neuroscience
- Genetics
Background:
- Individual differences in motion sickness (MS) susceptibility are significant.
- The caudal vestibular nucleus (CVN) plays a crucial role in processing motion stimuli.
- Understanding the molecular basis of MS susceptibility is essential for developing effective treatments.
Purpose of the Study:
- To identify genes differentially expressed in the rat CVN associated with motion sickness susceptibility.
- To investigate the functional role of these genes in motion sickness behavior and physiological responses.
Main Methods:
- Rats were classified as motion sickness susceptible (MSS) or insusceptible (inMSS) based on behavioral responses to rotation.
- Microarray analysis was performed on CVN tissue to identify differentially expressed genes.
- Quantitative real-time PCR (RT-qPCR) was used to validate gene expression findings.
- Pharmacological and genetic manipulations targeting candidate genes were conducted in the CVN.
Main Results:
- 304 transcripts were differentially expressed between MSS and inMSS rats.
- Key candidate genes identified include nicotinic cholinergic receptor (nAchR) α3 subunit, 5-hydroxytryptamine receptor 4 (5-HT4R), and tachykinin neurokinin-1 (NK1R).
- Administration of an nAchR antagonist (mecamylamine) reduced MS symptoms and plasma β-endorphin levels in MSS rats.
- NK1R antagonist and Olfactory Receptor 81 (Olr81) knockdown affected defecation responses, while 5-HT4R antagonist and Shc1 overexpression had no significant effect.
Conclusions:
- Variations in CVN gene expression after motion stimulation contribute to individual differences in MS susceptibility.
- Specific genes, such as nAchR α3 and NK1R, are potential therapeutic targets for motion sickness.
- These findings provide a molecular basis for understanding MS variability and developing novel treatment strategies.
Related Concept Videos
Equilibrium and Balance
The Vestibular System
Pathophysiology of Vomiting

